Elevación de transaminasas secundaria a uso de adalimumab

Statistics

Carta al editor

Transaminase elevation secondary to the use of adalimumab

Marietta Luz Juan-Guardelaa, Lisseth Fernanda Marín-Carrilloa, Laura Ximena Kattah-Martíneza, Daniel G. Fernández-Ávilab,

a Departamento de Medicina Interna, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Bogotá, Colombia

b Unidad de Reumatología, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Grupo Javeriano de Investigación en Enfermedades Reumáticas, Bogotá, Colombia

Read

16056

Times
was read the article

3871

Total PDF

12185

Total HTML

Share statistics

Article information

ISSN: 1699258X
Original language: Spanish

DOI:10.1016/j.reuma.2013.11.010

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 6	2	1	3
2025 5	242	48	290
2025 4	236	38	274
2025 3	228	25	253
2025 2	281	48	329
2025 1	233	40	273
2024 12	178	28	206
2024 11	180	69	249
2024 10	179	44	223
2024 9	142	20	162
2024 8	148	34	182
2024 7	205	38	243
2024 6	184	34	218
2024 5	244	49	293
2024 4	206	24	230
2024 3	213	37	250
2024 2	165	34	199
2024 1	169	22	191
2023 12	113	18	131
2023 11	127	57	184
2023 10	156	31	187
2023 9	158	40	198
2023 8	133	15	148
2023 7	160	31	191
2023 6	158	38	196
2023 5	165	32	197
2023 4	135	28	163
2023 3	140	25	165
2023 2	182	44	226
2023 1	116	21	137
2022 12	111	40	151
2022 11	120	54	174
2022 10	110	38	148
2022 9	124	50	174
2022 8	114	60	174
2022 7	88	47	135
2022 6	95	55	150
2022 5	100	56	156
2022 4	96	48	144
2022 3	103	61	164
2022 2	82	79	161
2022 1	100	39	139
2021 12	60	51	111
2021 11	67	53	120
2021 10	103	53	156
2021 9	77	57	134
2021 8	73	46	119
2021 7	81	41	122
2021 6	73	41	114
2021 5	102	53	155
2021 4	198	118	316
2021 3	129	73	202
2021 2	106	46	152
2021 1	78	42	120
2020 12	73	43	116
2020 11	78	44	122
2020 10	77	30	107
2020 9	67	43	110
2020 8	48	39	87
2020 7	49	30	79
2020 6	52	40	92
2020 5	59	31	90
2020 4	69	28	97
2020 3	50	29	79
2020 2	87	33	120
2020 1	92	32	124
2019 12	63	33	96
2019 11	84	32	116
2019 10	79	35	114
2019 9	93	31	124
2019 8	100	28	128
2019 7	125	32	157
2019 6	96	34	130
2019 5	134	52	186
2019 4	95	27	122
2019 3	74	20	94
2019 2	57	27	84
2019 1	74	25	99
2018 12	146	50	196
2018 11	206	20	226
2018 10	147	12	159
2018 9	58	7	65
2018 8	39	9	48
2018 7	25	10	35
2018 5	4	0	4
2018 4	63	3	66
2018 3	91	5	96
2018 2	51	2	53
2018 1	42	4	46
2017 12	40	4	44
2017 11	50	12	62
2017 10	45	7	52
2017 9	39	11	50
2017 8	46	6	52
2017 7	41	10	51
2017 6	49	4	53
2017 5	60	9	69
2017 4	53	4	57
2017 3	38	26	64
2017 2	54	9	63
2017 1	48	6	54
2016 12	63	21	84
2016 11	63	15	78
2016 10	106	29	135
2016 9	100	13	113
2016 8	61	8	69
2016 7	53	26	79
2016 2	1	0	1
2015 12	2	0	2
2015 9	2	0	2
2015 8	1	0	1
2015 7	22	7	29
2015 6	61	29	90
2015 5	74	35	109
2015 4	92	21	113
2015 3	35	22	57
2015 2	38	15	53
2015 1	57	31	88
2014 12	48	24	72
2014 11	62	22	84
2014 10	65	39	104
2014 9	57	19	76
2014 8	95	44	139
2014 7	118	92	210
2014 6	31	17	48

Show all

Indexed in:

Follow us:

Subscribe:

Statistics

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter